This led to inhibition of SREBP1 and its targets such as fatty acid synthase (FASN), acetyl-CoA Carboxylase (ACC), and ATP Citrate Lyase (ACLY), suggesting the regulation of lipid metabolism by FXR in PCa which decreased cell proliferation in LNCaP cells [230]. The gene discussed is FASN; the disease is posterior cortical atrophy.